IonQ (NYSE:IONQ) Coverage Initiated at Rosenblatt Securities

Key Points

• Rosenblatt Securities has initiated coverage on IonQ with a "buy" rating and a target price of $70.00, indicating a potential upside of 65.13% from the last closing price.
• IonQ's recent quarterly earnings showed a loss of ($0.14) EPS, surpassing estimates, and revenue of $7.57 million, which was slightly above expectations.
• Insider trading reports indicate significant activity, with one insider selling 3.58 million shares, reducing their position by over 90%.

Equities research analysts at Rosenblatt Securities assumed coverage on shares of IonQ (NYSE:IONQ - Get Free Report) in a research note issued to investors on Tuesday,Briefing.com Automated Import reports. The brokerage set a "buy" rating and a $70.00 price target on the stock. Rosenblatt Securities' price target indicates a potential upside of 65.13% from the stock's previous close.

Several other analysts also recently weighed in on IONQ. Cantor Fitzgerald started coverage on IonQ in a report on Wednesday, July 2nd. They issued an "overweight" rating and a $45.00 target price for the company. Morgan Stanley lifted their target price on shares of IonQ from $29.00 to $30.00 and gave the company an "equal weight" rating in a report on Thursday, May 8th. DA Davidson cut their target price on shares of IonQ from $50.00 to $35.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Benchmark lifted their target price on shares of IonQ from $50.00 to $55.00 and gave the company a "buy" rating in a report on Monday, July 7th. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $50.00 target price on shares of IonQ in a report on Wednesday, June 11th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $45.00.

IonQ Stock Performance

NYSE:IONQ opened at $42.39 on Tuesday. The stock has a 50-day simple moving average of $41.85 and a 200-day simple moving average of $34.11. The stock has a market cap of $11.09 billion, a P/E ratio of -28.45 and a beta of 2.55. IonQ has a 1 year low of $6.22 and a 1 year high of $54.74.

IonQ (NYSE:IONQ - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.14. IonQ had a negative return on equity of 63.35% and a negative net margin of 753.20%. The business had revenue of $7.57 million during the quarter, compared to analysts' expectations of $7.51 million. During the same period in the prior year, the firm posted ($0.19) EPS. The business's quarterly revenue was down .2% compared to the same quarter last year. On average, equities research analysts predict that IonQ will post -0.86 EPS for the current year.

Insider Buying and Selling

In other IonQ news, insider Peter Hume Chapman sold 3,581,193 shares of IonQ stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $38.13, for a total value of $136,550,889.09. Following the sale, the insider owned 390,329 shares of the company's stock, valued at approximately $14,883,244.77. The trade was a 90.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CRO Rima Alameddine sold 65,000 shares of IonQ stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $38.57, for a total value of $2,507,050.00. Following the completion of the sale, the executive directly owned 552,592 shares in the company, valued at $21,313,473.44. This represents a 10.52% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 9,191,850 shares of company stock worth $360,519,930. Insiders own 5.20% of the company's stock.

Institutional Investors Weigh In On IonQ

A number of institutional investors have recently added to or reduced their stakes in the business. Mariner LLC grew its stake in shares of IonQ by 0.6% during the 4th quarter. Mariner LLC now owns 54,479 shares of the company's stock worth $2,276,000 after purchasing an additional 350 shares during the period. Future Financial Wealth Managment LLC grew its stake in shares of IonQ by 50.0% during the 1st quarter. Future Financial Wealth Managment LLC now owns 1,500 shares of the company's stock worth $33,000 after purchasing an additional 500 shares during the period. Miracle Mile Advisors LLC lifted its position in shares of IonQ by 2.5% during the 1st quarter. Miracle Mile Advisors LLC now owns 20,500 shares of the company's stock valued at $452,000 after acquiring an additional 500 shares during the period. Measured Risk Portfolios Inc. acquired a new stake in shares of IonQ during the 4th quarter valued at approximately $27,000. Finally, Signaturefd LLC lifted its position in shares of IonQ by 20.7% during the 1st quarter. Signaturefd LLC now owns 4,048 shares of the company's stock valued at $89,000 after acquiring an additional 694 shares during the period. Hedge funds and other institutional investors own 41.42% of the company's stock.

IonQ Company Profile

IonQ, Inc engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft's Azure Quantum, and Google's Cloud Marketplace, as well as through its cloud service.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.